Technical Analysis for CBMG - Cellular Biomedicine Group, Inc.

Grade Last Price % Change Price Change
grade D 16.86 -1.58% -0.27
CBMG closed down 1.58 percent on Friday, May 17, 2019, on 74 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical CBMG trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
NR7 Range Contraction 0.00%
50 DMA Resistance Bearish -1.58%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.58%
Crossed Above 20 DMA Bullish -1.58%
MACD Bullish Signal Line Cross Bullish -1.58%
Pocket Pivot Bullish Swing Setup -1.58%
Up 3 Days in a Row Strength -1.58%
Lower Bollinger Band Walk Weakness 1.93%
Stochastic Buy Signal Bullish 4.85%

Older signals for CBMG ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Cellular Biomedicine Group Inc., a biomedicine company, engages in the development of treatments for cancerous and degenerative diseases in Greater China. The company focuses on developing and marketing cell-based therapeutic products to treat serious chronic and degenerative diseases, including cancer, osteoarthritis, tissue damage, spinal muscular atrophy, various inflammatory diseases, and joint diseases. It is developing treatments utilizing proprietary cell technologies, which include tumor cell specific dendritic cells for the treatment of a range of cancers; human adipose-derived mesenchymal progenitor cells for the treatment of joint disease; human umbilical cord-derived mesenchymal progenitor cells; human embryo-derived motor neuron progenitor precursor cells; and human embryo-derived neuronal progenitor precursor cells for the treatment of central nervous system diseases. The company is headquartered in Palo Alto, California.
Cancer Life Sciences Biology Cancers Stem Cells Tumor Osteoarthritis Inflammatory Diseases Spinal Muscular Atrophy Stem Cell Therapy Central Nervous System Diseases Degenerative Disease Treatment Of Central Nervous System Diseases Mesenchymal Stem Cell Treatment Of A Range Of Cancers
Is CBMG a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 25.0
52 Week Low 12.04
Average Volume 46,236
200-Day Moving Average 18.0996
50-Day Moving Average 17.1218
20-Day Moving Average 16.7105
10-Day Moving Average 16.483
Average True Range 0.7246
ADX 11.39
+DI 19.7609
-DI 17.6189
Chandelier Exit (Long, 3 ATRs ) 15.7662
Chandelier Exit (Short, 3 ATRs ) 17.3638
Upper Bollinger Band 17.6908
Lower Bollinger Band 15.7302
Percent B (%b) 0.58
BandWidth 11.732743
MACD Line -0.1862
MACD Signal Line -0.2364
MACD Histogram 0.0502
Fundamentals Value
Market Cap 237.87 Million
Num Shares 14.1 Million
EPS -2.06
Price-to-Earnings (P/E) Ratio -8.18
Price-to-Sales 587.89
Price-to-Book 2.44
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.51
Resistance 3 (R3) 17.48 17.24 17.40
Resistance 2 (R2) 17.24 17.08 17.25 17.36
Resistance 1 (R1) 17.05 16.97 16.93 17.08 17.33
Pivot Point 16.81 16.81 16.75 16.82 16.81
Support 1 (S1) 16.62 16.65 16.50 16.65 16.39
Support 2 (S2) 16.38 16.54 16.39 16.36
Support 3 (S3) 16.19 16.38 16.32
Support 4 (S4) 16.22